Researchers from the University Medical Center Hamburg-Eppendorf and the University Hospital Bonn have demonstrated that certain derivatives of vitamin B2 can alleviate chronic kidney inflammation in mice. Their findings ...
Nov 21, 2023
0
152
An international clinical trial involving UC Davis Health suggests the investigational drug Elafibranor is a potential novel treatment for patients with the rare, autoimmune disease primary biliary cholangitis. Results from ...
Nov 16, 2023
0
16
In a new study, investigators at Beth Israel Deaconess Medical Center (BIDMC) have shed new light on key cellular processes involved in the progression of Parkinson's disease (PD). The research is published in the journal ...
Nov 14, 2023
0
44
A simple blood test into multiple sclerosis (MS) pathology could speed MS diagnostics and ultimately improve patient care, according to Xiaoli Yu, Ph.D., senior author of a new study on plasma immunoglobulin G (IgG) antibody ...
Nov 9, 2023
0
0
Researchers have identified genetic tests that predict which cancer patients may benefit from the drugs in combination with chemotherapy.
Nov 6, 2023
0
0
The centuries-old martial art of tai chi is shown to have many health benefits—including improving balance, reducing anxiety and preventing cardiovascular disease.
Nov 4, 2023
0
2
Research led by the University of Minnesota Medical School identified a new pathway to combat cardiovascular disease. The study was recently published in Nature Cardiovascular Research.
Nov 3, 2023
0
54
AI (artificial intelligence) that is trained to recognize red flags in retinal images and clinical information can predict if and when people at high risk of glaucoma, usually referred to as "glaucoma suspects," go on to ...
Nov 3, 2023
0
30
There is no cure for progressive supranuclear palsy (PSP), a brain disorder marked by walking and balance difficulties. Its symptoms also mimic Parkinson's disease and dementia. The condition leads to rapid, progressive decline ...
Nov 3, 2023
0
49
For patients with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma, pembrolizumab improves progression-free survival when combined with chemotherapy and trastuzumab, according to a study published online Oct. ...
Oct 25, 2023
0
1
